

Please try another search
J.P. Morgan analyst Cory Kasimov maintained a Hold rating on Moderna (NASDAQ:MRNA) Inc on Monday, setting a price target of $89, which is approximately 28.50% above the present share price of $69.26.
Kasimov expects Moderna Inc to post earnings per share (EPS) of -$0.31 for the third quarter of 2020.
The current consensus among 14 TipRanks analysts is for a Moderate Buy rating of shares in Moderna, with an average price target of $91.86.
The analysts price targets range from a high of $134 to a low of $41.
In its latest earnings report, released on 06/30/2020, the company reported a quarterly revenue of $66.35 million and a net profit of -$122.13 million. The company's market cap is $27.33 billion.
According to TipRanks.com, J.P. Morgan analyst Cory Kasimov is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 19.7% and a 55.17% success rate.
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.